Activated kinases in ALL: time to act
Author:
Open Access
- 22 June 2017
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 129 (25) , 3280-3282
Abstract
In this issue of Blood, Reshmi et al1 report a study that defines a protocol for identifying kinase-driven high-risk (HR) features, known as “Ph-like” expression profile, in patients with acute lymphocytic leukemia (ALL). Revealing the underlying genetic aberration allows better prognostication and may point to potential therapeutic options for specific patients. Originally identified in pediatric patients, this Ph-like or kinase-driven ALL (KD-ALL) subtype has also been found to be common among adults.2,3 The journey to the routine identification of these kinase-activating genetic alternations started 8 years ago and required extensive efforts and use of different laboratory methods to become feasible. The most important take-home message from this work is that the time has come for routine screening for kinase-activating alterations in ALL. Although this study is published before clinical outcome data of the patients enrolled in the Children’s Oncology Group study have matured, the clinical significance of identification of KD-ALL is well established.4 Reshmi et al confirm the complexity of the genetic alteration map of these potentially targetable aberrations. The authors also provide a working diagnostic paradigm starting with a simple gene expression screening test, which reliably identifies patients in whom genetic testing for kinase-activating alterations is futile. Of 202 patients whose suggested score for screening was below 0.5, only in 1 was a potentially targetable fusion detected (HOOK3-FGFR1 genes).Keywords
This publication has 5 references indexed in Scilit:
- Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupBlood, 2017
- BCR-ABL (Ph)-like acute leukemia—Pathogenesis, diagnosis and therapeutic optionsBlood Reviews, 2017
- Ph-like acute lymphoblastic leukemia: a high-risk subtype in adultsBlood, 2017
- High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsJournal of Clinical Oncology, 2017
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016